MedPath

A Study Of Nishadi Taila In Treatment Of Nabhi paka In Newborns

Phase 2/3
Recruiting
Conditions
Omphalitis without hemorrhage. Ayurveda Condition: NABIVIDRADHIH,
Registration Number
CTRI/2023/03/050294
Lead Sponsor
Dr.Shital Patil
Brief Summary

This is single arm clinical study in which Medicinal oil Nishadi Taila will be provided to 35 patients showing classical signs and symptoms of Nabhi paka for relieving symptoms 

The age group taken for study trail will be between 1 day to 1 month Nishadi Tail will be locally applied twice a day daily till 5 days Follow up will be daily one to five days. Total duration of case study will be 5 days

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
35
Inclusion Criteria

1 Newborn baby of age group from birth upto 1 month 2 Newborn baby having sign and symptoms of Nabhi paka like redness tenderness infammation and pus discharge from umbilicus 3 The patients whose parents are ready to participate in clinical trial by giving informed written consent.

Exclusion Criteria

1 Baby born with thick meconium stained liquor 2 Baby with meconium aspiration syndrome 3 Baby having other major illnesses like cardiac neurological diseases.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To reduce symptoms of Nabhi paka like redness, inflammation, swelling at umbilicusDaily one to five days
Secondary Outcome Measures
NameTimeMethod
To access healing of umbilical wound.Daily one to five days

Trial Locations

Locations (1)

Dr.D.Y.PATIL College Of Ayurved and Research Centre,Sant Tukaram Nagar,Pimpri,Pune411018

🇮🇳

Pune, MAHARASHTRA, India

Dr.D.Y.PATIL College Of Ayurved and Research Centre,Sant Tukaram Nagar,Pimpri,Pune411018
🇮🇳Pune, MAHARASHTRA, India
DrShital Patil
Principal investigator
7666705147
shitalpatil701@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.